CorMedix (CRMD) has a profit margin of 15.49%, below the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
The latest profit margin for CRMD is 15.49% as of September 2026. That compares with 104.05% in the prior-year period — down 85.1% year over year. That is below the Healthcare sector average of 17.63%. Investors often review this figure alongside CorMedix's historical trend and sector peers before judging valuation or financial health.
Over the past year, CRMD's profit margin moved from 104.05% to 15.49% — a 85.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in CorMedix's valuation or profitability profile.
Against Healthcare companies, CRMD currently prints 15.49% for profit margin, while the sector average sits near 17.63%. That is roughly 12.1% below the sector mean. Large gaps often invite a closer look at CorMedix's growth, margins, and balance sheet.
Profit Margin shows how effectively CorMedix converts resources into returns. At 15.49%, CRMD may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 104.05% in the prior-year period — down 85.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting CRMD's profit margin (15.49%), review year-over-year change from 104.05%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.